Revolution Medicines, Inc. RVMD Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $440.94M+14.9% | $383.75M+76.5% | $217.44M-46.0% | $402.44M+20.7% | $333.55M-38.6% | ||
| $1.47B-10.6% | $1.64B-4.2% | $1.71B-1.2% | $1.73B-1.9% | $1.77B+1.3% | ||
| $4.86M0.0% | $4.86M0.0% | $4.86M+24.1% | $3.92M+5.9% | $3.7M0.0% | ||
| $59.83M+21.2% | $49.36M+7.3% | $45.98M+17.1% | $39.27M+23.1% | $31.91M-16.8% | ||
| $1.97B-5.2% | $2.08B+4.9% | $1.98B-9.1% | $2.18B+2.0% | $2.13B-8.3% | ||
| $31.48M-5.2% | $33.19M+0.8% | $32.93M-0.4% | $33.05M+21.7% | $27.15M+11.8% | ||
| $129.9M-1.7% | $132.08M-1.8% | $134.45M+17.9% | $114M-1.5% | $115.78M-1.5% | ||
| $14.61M0.0% | $14.61M0.0% | $14.61M0.0% | $14.61M0.0% | $14.61M0.0% | ||
| $55.8M0.0% | $55.8M-0.1% | $55.87M-0.5% | $56.14M-0.5% | $56.4M-0.5% | ||
| $14.48M-2.0% | $14.78M-0.6% | $14.87M-52.7% | $31.42M+139% | $13.13M+654% | ||
| $2.25B-4.3% | $2.35B+4.6% | $2.25B-7.3% | $2.43B+2.7% | $2.37B-7.5% | ||
| $80.54M+24.6% | $64.62M-13.7% | $74.85M+31.9% | $56.76M+19.5% | $47.51M-12.7% | ||
| $16.61M+0.9% | $16.47M+0.9% | $16.33M+24.7% | $13.09M+0.8% | $12.98M+0.8% | ||
| $289.6M-0.3% | $290.42M+18.2% | $245.62M+33.1% | $184.53M+16.4% | $158.6M-3.2% | ||
| $140.02M-1.6% | $142.23M+0.1% | $142.14M+18.7% | $119.7M-1.4% | $121.36M-1.3% | ||
| $156.63M-1.3% | $158.7M+0.2% | $158.46M+19.3% | $132.79M-1.2% | $134.34M-1.1% | ||
| $6.88M+469% | $1.21M-51.3% | $2.48M-65.6% | $7.2M+74.1% | $4.14M+518% | ||
| $753.82M+4.2% | $723.21M+10.4% | $655.02M+16.1% | $564.2M+96.4% | $287.2M-2.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $19K0.0% | $19K+5.6% | $18K0.0% | $18K0.0% | $18K0.0% | ||
| $4.82B+7.3% | $4.5B+9.7% | $4.1B+0.9% | $4.06B+0.9% | $4.03B+0.6% | ||
| -$3.32B-15.8% | -$2.87B-14.6% | -$2.5B-13.9% | -$2.2B-12.7% | -$1.95B-12.3% | ||
| -$622K-119% | $3.24M+3.9% | $3.12M+139% | $1.3M-23.7% | $1.71M+29.2% | ||
| $1.5B-8.1% | $1.63B+2.2% | $1.6B-14.4% | $1.87B-10.2% | $2.08B-8.3% | ||
| $2.25B-4.3% | $2.35B+4.6% | $2.25B-7.3% | $2.43B+2.7% | $2.37B-7.5% | ||
| $1.47B-10.6% | $1.64B-4.2% | $1.71B-1.2% | $1.73B-1.9% | $1.77B+1.3% | ||
| $14.48M-2.0% | $14.78M-0.6% | $14.87M-52.7% | $31.42M+139% | $13.13M+654% | ||
| $34.71M+43.7% | $24.15M+43.3% | $16.85M— | —— | —— | ||
| $129.9M-1.7% | $132.08M-1.8% | $134.45M+17.9% | $114M-1.5% | $115.78M-1.5% | ||
| $55.8M0.0% | $55.8M-0.1% | $55.87M-0.5% | $56.14M-0.5% | $56.4M-0.5% | ||
| $129.9M-1.7% | $132.08M-1.8% | $134.45M+17.9% | $114M-1.5% | $115.78M-1.5% | ||
| $14.48M-2.0% | $14.78M-0.6% | $14.87M-52.7% | $31.42M+139% | $13.13M+654% | ||
| $129.9M-1.7% | $132.08M-1.8% | $134.45M+17.9% | $114M-1.5% | $115.78M-1.5% | ||
| $14.48M-2.0% | $14.78M-0.6% | $14.87M-52.7% | $31.42M+139% | $13.13M+654% | ||
| $280.64M+4.5% | $268.45M+4.7% | $256.51M+4.7% | $245.08M— | —— | ||
| $192.45M-8.1% | $209.34M+35.5% | $154.45M+34.7% | $114.69M+16.9% | $98.11M+1.6% | ||
| $4.82B+7.3% | $4.5B+9.7% | $4.1B+0.9% | $4.06B+0.9% | $4.03B+0.6% | ||
| $19K0.0% | $19K+5.6% | $18K0.0% | $18K0.0% | $18K0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $280.64M+4.5% | $268.45M+4.7% | $256.51M+4.7% | $245.08M— | —— | ||
| $2.35M0.0% | $2.35M0.0% | $2.35M0.0% | $2.35M0.0% | $2.35M0.0% | ||
| $34.33M+85.1% | $18.55M+213% | $5.92M+11.1% | $5.33M+610% | $750K-76.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Revolution Medicines, Inc.'s total assets?
- Revolution Medicines, Inc. (RVMD) holds $2.3B in total assets, down 4.7% year over year.
- How much debt does Revolution Medicines, Inc. have?
- Revolution Medicines, Inc. carries $156.6M in total debt against $1.5B of shareholders' equity, a debt-to-equity ratio of 0.10.
- How much cash does Revolution Medicines, Inc. have?
- Revolution Medicines, Inc. holds $440.9M in cash and equivalents.
- Can Revolution Medicines, Inc. cover its short-term obligations?
- Its current ratio is 6.80 — current assets exceed current liabilities.
- Where does Revolution Medicines, Inc.'s balance sheet data come from?
- Every line is extracted from Revolution Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.